What is Inhibrx Biosciences, Inc.'s compensation and benefits?

Inhibrx Biosciences, Inc. (INBX) reported compensation and benefits of $2.24M in Q1 2026.

How has Inhibrx Biosciences, Inc.'s compensation and benefits changed year-over-year?

Inhibrx Biosciences, Inc.'s compensation and benefits decreased by 17.5% year-over-year, from $2.72M to $2.24M.

What is the long-term trend for Inhibrx Biosciences, Inc.'s compensation and benefits?

Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s compensation and benefits has grown at a 7.0% compound annual growth rate (CAGR), from $6.51M to $7.45M.

Inhibrx Biosciences, Inc. INBX Compensation and benefits

Compensation and benefits at other companies

PfizerPFE

——

Arcus BiosciencesRCUS

——

Summit TherapeuticsSMMT

——

Nektar TherapeuticsNKTR

——

IncyteINCY

——

BridgeBio PharmaBBIO

——

Other financials

Income statement

See full

Revenue--100%

Operating income-$30.9M+27.9%

Net income-$33.4M+22.8%

EPS (diluted)-$2.15+23.2%

Balance sheet

See full

Cash & equivalents$161.7M-25.3%

Total debt$180.9M+69.8%

Total equity-$21.0M-122%

Total assets$184.0M-24.2%

Cash flow

See full

Operating cash flow-$38.0M-5.9%

CapEx--100%

Free cash flow-$38.0M-5.9%

Valuation

See full

Market cap$1.4B+385%

Enterprise value$1.42B+982%

P/S1,073.7×-280×

Profitability

See full

Operating margin-10,386.5%-5,025pp

Net margin-10,773.5%-878,492pp

FCF margin-9,986.5%-4,727pp

Returns & leverage

See full

Return on equity-197.8%-2,158pp

Debt / equity13.4×+13.3×

Current ratio6.5×+1.3×

Where this comes from

Reported directly by Inhibrx Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inhibrx Biosciences, Inc.'s compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Inhibrx Biosciences, Inc.'s compensation and benefits?: Inhibrx Biosciences, Inc. (INBX) reported compensation and benefits of $2.24M in Q1 2026.
How has Inhibrx Biosciences, Inc.'s compensation and benefits changed year-over-year?: Inhibrx Biosciences, Inc.'s compensation and benefits decreased by 17.5% year-over-year, from $2.72M to $2.24M.
What is the long-term trend for Inhibrx Biosciences, Inc.'s compensation and benefits?: Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s compensation and benefits has grown at a 7.0% compound annual growth rate (CAGR), from $6.51M to $7.45M.